# Bryophyllum Pinnatum Treatment of Anxiety Related to Signs of Preterm Birth

> **NCT05110599** · PHASE2 · TERMINATED · sponsor: **Christian Haslinger** · enrollment: 60 (actual)

## Conditions studied

- Preterm Labor
- Anxiety

## Interventions

- **DRUG:** Bryophyllum 50% chewable tablets
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05110599
- **Lead sponsor:** Christian Haslinger
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-07-12
- **Primary completion:** 2023-08-25
- **Final completion:** 2023-10-01
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** Slow recruitment and expired study medication.
- **Last updated:** 2023-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05110599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05110599, "Bryophyllum Pinnatum Treatment of Anxiety Related to Signs of Preterm Birth". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05110599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*